WebApr 10, 2024 · Vancouver, British Columbia--(Newsfile Corp. - April 10, 2024) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQX: NGENF) ("NervGen" or the "Company"), a … Web6 hours ago · NervGen Pharma Completes Dosing in Its Third Multiple Ascending Dose Cohort in Phase 1 Clinical Trial of NVG-291 and Reports Q3 2024 Results: Vancouver, BC, December 13, 2024--NervGen Pharma Corp. , a clinical stage biotech company dedicated to developing innovative solutions for the treatment of nervous system damage, reported …
NervGen Pharma Appoints Michael Kelly as President & Chief …
WebApr 10, 2024 · NervGen Pharma. NervGen (TSX-V: NGEN, OTCQX: NGENF) is a clinical stage biotech company creating innovative treatments that enable the nervous system to … WebVancouver, Canada-- (Newsfile Corp. - February 23, 2024) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQX: NGENF) ("NervGen" or the "Company"), a clinical stage biotech company dedicated to developing innovative solutions for the treatment of nervous system damage, announced that the Company has granted 285,000 incentive stock options to … ordering whole numbers video
NervGen Pharma Appoints Michael Kelly as President & Chief …
WebVancouver, Canada-- (Newsfile Corp. - February 23, 2024) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQX: NGENF) ("NervGen" or the "Company"), a clinical stage … Web6 hours ago · Vancouver, BC, April 14, 2024--(T-Net)--NervGen Pharma Corp. (TSX-V: NGEN; OTCQX: NGENF), a clinical stage biotech company dedicated to developing innovative solutions for the treatment of nervous system damage, today announced the appointment of Mr. Michael Kelly to the position of President & CEO effective April 10, … WebGet the latest NervGen Pharma Corp (NGENF) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. ordering wholesale flowers